Grafa News and Videos — Page 866

Voyager Therapeutics (NASDAQ:VYGR) achieved a critical regulatory milestone this week, presenting positive three-month toxicology data for its lead Alzheimer’s disease candidate, VY1706.

Global-e Online (NASDAQ:GLBE) reported a pivotal shift in its financial performance for the first quarter of 2026, swinging to a GAAP net profit as its cross-border e-commerce platform captured a record volume of international trade.

Zenas BioPharma (NASDAQ:ZBIO) announced that it is on track to transition into a commercial-stage company, with plans to submit its first Biologics License Application (BLA) to the U.S. Food and Drug Administration this quarter.

Atour Lifestyle Holdings (NASDAQ:ATAT) reported a robust start to fiscal year 2026, delivering triple-digit profit momentum and aggressive top-line growth.

National Vision Holdings (NASDAQ:EYE) delivered a sharp increase in profitability for the first quarter of 2026, as successful pricing initiatives and a shift toward managed care customers bolstered the company’s bottom line.

Boyd Group Services (NYSE:BGSI) delivered record-breaking financial results for the first quarter of 2026, as the company reaped the initial benefits of its transformative $1.3 billion acquisition of Joe Hudson’s Collision Center.

Regis Corporation (NASDAQ:RGS) demonstrated improved operational efficiency in its third fiscal quarter, reporting a significant rise in net income and earnings per share despite a contraction in its top-line revenue.

WeRide (NASDAQ:WRD) reported record unaudited financial results for the first quarter of 2026, as the company’s aggressive international expansion into fare-charging robotaxi services began to scale.

Birkenstock Holding (NYSE:BIRK) revealed a surge in quarterly sales that matched its aggressive growth ambitions, though bottom-line results were pinched by escalating trade costs and unfavorable currency movements.

Alibaba Group Holding (NYSE:BABA) reported a complex set of financial results for the quarter and fiscal year ended March 31, 2026, revealing a company in the midst of an expensive strategic pivot.